OTC Pet Medication Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
The global OTC Pet Medication market is experiencing significant growth and is expected to continue expanding in the forecast period. By the end of 2031, the market is expected to reach an impressive valuation of approximately US$ 14.1 billion, up from its 2024 size of around US$ 9.47 billion.
The Humanization of Pets Fuels Demand for OTC Pet Medication
The phenomenon known as pet humanization is at the heart of the surging demand for OTC pet medications. Increasingly, pets are considered integral members of the family, leading to a parallel rise in the demand for pet medications and other medicated products and services. This shift in perspective is bolstered by the growing rate of pet adoption and increased per-person spending on pets. People now care for their dogs with the same devotion as parents caring for their children, solidifying the status of pets as cherished family members.
Why the U.S. Leads the Global OTC Veterinary Drugs Market
The United States is at the forefront of the global OTC pet medication market, driven by the burgeoning pet care industry and the proliferation of online pharmacies. In 2021, over 3.5 million pets were covered under insurance in the U.S., according to the North American Pet Health Insurance Association (NAPHIA). The country's pet adoption rates continue to rise, thanks to pet insurance companies actively promoting awareness and product understanding among pet owners.
Expansive Opportunities in the Chinese OTC Pet Medication Market
China is experiencing remarkable growth in the OTC pet medication market, driven by several key factors. The nation's expanding population of companion animals, the trend of pet humanization, the prevalence of animal ailments, and initiatives by major companies have all contributed to market expansion. For instance, Boehringer Ingelheim became the first multinational animal health company to enter the horse business in China after being granted a license by the Chinese Ministry of Agriculture and Rural Affairs in 2021 for its GastroGard medication formulated for horses.
Competitive Landscape Analysis
The global OTC pet medication market is characterized by consolidation, with most players focusing on product development, regular launches, and strategic mergers and acquisitions. Leading OTC pet medication manufacturers are actively engaging in collaborations and acquiring niche players to strengthen their market positions.
Key Companies Driving the OTC Pet Medication Market
• Bayer Companion Animal
• Boehringer Ingelheim Animal Health
• Ceva Sante Animale
• Merck Inc.
• Zoetis Inc.
• Elanco
• Virbac SA
• Vetoquinol SA
• Frontline
• Zymox
• ChloraSeb
• Sulfox
• Adequan
• Dechra Pharmaceuticals PLC
• Nutramax Laboratories, Inc.
• Others (As per Request)
The global OTC pet medication market is poised for robust and sustained growth in the coming years, driven by the increasing humanization of pets, rising pet adoption rates, and a commitment to pet health and well-being.
Key Segments Covered in OTC Pet Medication Industry Research
OTC Pet Medication Market by Product Type:
• Fleas & Ticks
• Pain Relief & Arthritis
• Dewormers
• Others
OTC Pet Medication Market by Pet Type:
• Dogs
• Cats
• Birds
• Fish & Reptiles
• Small Pets
• Others
OTC Pet Medication Market by Medicine Form:
• Chewable & Tablets
• Capsules & Ointment
• Sprays
• Others
OTC Pet Medication Market by Sales Channel:
• Pet Specialty Stores
• Veterinary Clinics
• Drug & Pharmacy Stores
• Online Retail
• Others
OTC Pet Medication Market by Region:
• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East Africa
Please note: The PDF e-mail from publisher version of this report is for a global site license. Delivery Timelines - 5 working days.
- 1. Executive Summary
- 1.1. Global OTC Pet Medication Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2023
- 1.5. Analyst Recommendations
- 2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. Porter’s Five Forces Analysis
- 2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
- 2.6. Impact of Ukraine-Russia Conflict
- 2.7. Economic Overview
- 2.7.1. World Economic Projections
- 2.8. PESTLE Analysis
- 3. Global OTC Pet Medication Market Outlook, 2018 – 2031
- 3.1. Global OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 3.1.1. Key Highlights
- 3.1.1.1. Fleas & Ticks
- 3.1.1.2. Pain Relief & Arthritis
- 3.1.1.3. Dewormers
- 3.1.1.4. Others
- 3.2. Global OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 – 2031
- 3.2.1. Key Highlights
- 3.2.1.1. Dogs
- 3.2.1.2. Cats
- 3.2.1.3. Birds
- 3.2.1.4. Fish & Reptiles
- 3.2.1.5. Small Pets
- 3.2.1.6. Others
- 3.3. Global OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 – 2031
- 3.3.1. Key Highlights
- 3.3.1.1. Chewable & Tablets
- 3.3.1.2. Capsules & Ointment
- 3.3.1.3. Sprays
- 3.3.1.4. Others
- 3.4. Global OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 – 2031
- 3.4.1. Key Highlights
- 3.4.1.1. Pet Specialty Stores
- 3.4.1.2. Veterinary Clinics
- 3.4.1.3. Drug & Pharmacy Stores
- 3.4.1.4. Online Retail
- 3.4.1.5. Others
- 3.5. Global OTC Pet Medication Market Outlook, by Region, Value (US$ Bn), 2018 – 2031
- 3.5.1. Key Highlights
- 3.5.1.1. North America
- 3.5.1.2. Europe
- 3.5.1.3. Asia Pacific
- 3.5.1.4. Latin America
- 3.5.1.5. Middle East & Africa
- 4. North America OTC Pet Medication Market Outlook, 2018 – 2031
- 4.1. North America OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 4.1.1. Key Highlights
- 4.1.1.1. Fleas & Ticks
- 4.1.1.2. Pain Relief & Arthritis
- 4.1.1.3. Dewormers
- 4.1.1.4. Others
- 4.2. North America OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 – 2031
- 4.2.1. Key Highlights
- 4.2.1.1. Dogs
- 4.2.1.2. Cats
- 4.2.1.3. Birds
- 4.2.1.4. Fish & Reptiles
- 4.2.1.5. Small Pets
- 4.2.1.6. Others
- 4.3. North America OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 – 2031
- 4.3.1. Key Highlights
- 4.3.1.1. Chewable & Tablets
- 4.3.1.2. Capsules & Ointment
- 4.3.1.3. Sprays
- 4.3.1.4. Others
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
- 4.4. North America OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 – 2031
- 4.4.1. Key Highlights
- 4.4.1.1. Pet Specialty Stores
- 4.4.1.2. Veterinary Clinics
- 4.4.1.3. Drug & Pharmacy Stores
- 4.4.1.4. Online Retail
- 4.4.1.5. Others
- 4.4.2. BPS Analysis/Market Attractiveness Analysis
- 4.5. North America OTC Pet Medication Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 4.5.1. Key Highlights
- 4.5.1.1. U.S. OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 4.5.1.2. U.S. OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 4.5.1.3. U.S. OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 4.5.1.4. U.S. OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 4.5.1.5. Canada OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 4.5.1.6. Canada OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 4.5.1.7. Canada OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 4.5.1.8. Canada OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis
- 5. Europe OTC Pet Medication Market Outlook, 2018 – 2031
- 5.1. Europe OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 5.1.1. Key Highlights
- 5.1.1.1. Fleas & Ticks
- 5.1.1.2. Pain Relief & Arthritis
- 5.1.1.3. Dewormers
- 5.1.1.4. Others
- 5.2. Europe OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 – 2031
- 5.2.1. Key Highlights
- 5.2.1.1. Dogs
- 5.2.1.2. Cats
- 5.2.1.3. Birds
- 5.2.1.4. Fish & Reptiles
- 5.2.1.5. Small Pets
- 5.2.1.6. Others
- 5.3. Europe OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 – 2031
- 5.3.1. Key Highlights
- 5.3.1.1. Chewable & Tablets
- 5.3.1.2. Capsules & Ointment
- 5.3.1.3. Sprays
- 5.3.1.4. Others
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
- 5.4. Europe OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 – 2031
- 5.4.1. Key Highlights
- 5.4.1.1. Pet Specialty Stores
- 5.4.1.2. Veterinary Clinics
- 5.4.1.3. Drug & Pharmacy Stores
- 5.4.1.4. Online Retail
- 5.4.1.5. Others
- 5.4.2. BPS Analysis/Market Attractiveness Analysis
- 5.5. Europe OTC Pet Medication Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 5.5.1. Key Highlights
- 5.5.1.1. Germany OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.2. Germany OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.3. Germany OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 5.5.1.4. Germany OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.5. U.K. OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.6. U.K. OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.7. U.K. OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 5.5.1.8. U.K. OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.9. France OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.10. France OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.11. France OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 5.5.1.12. France OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.13. Italy OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.14. Italy OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.15. Italy OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 5.5.1.16. Italy OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.17. Turkey OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.18. Turkey OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.19. Turkey OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 5.5.1.20. Turkey OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.21. Russia OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.22. Russia OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.23. Russia OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 5.5.1.24. Russia OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 5.5.1.25. Rest of Europe OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.26. Rest of Europe OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 5.5.1.27. Rest of Europe OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 5.5.1.28. Rest of Europe OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis
- 6. Asia Pacific OTC Pet Medication Market Outlook, 2018 – 2031
- 6.1. Asia Pacific OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 6.1.1. Key Highlights
- 6.1.1.1. Fleas & Ticks
- 6.1.1.2. Pain Relief & Arthritis
- 6.1.1.3. Dewormers
- 6.1.1.4. Others
- 6.2. Asia Pacific OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 – 2031
- 6.2.1. Key Highlights
- 6.2.1.1. Dogs
- 6.2.1.2. Cats
- 6.2.1.3. Birds
- 6.2.1.4. Fish & Reptiles
- 6.2.1.5. Small Pets
- 6.2.1.6. Others
- 6.3. Asia Pacific OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 – 2031
- 6.3.1. Key Highlights
- 6.3.1.1. Chewable & Tablets
- 6.3.1.2. Capsules & Ointment
- 6.3.1.3. Sprays
- 6.3.1.4. Others
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
- 6.4. Asia Pacific OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 – 2031
- 6.4.1. Key Highlights
- 6.4.1.1. Pet Specialty Stores
- 6.4.1.2. Veterinary Clinics
- 6.4.1.3. Drug & Pharmacy Stores
- 6.4.1.4. Online Retail
- 6.4.1.5. Others
- 6.4.2. BPS Analysis/Market Attractiveness Analysis
- 6.5. Asia Pacific OTC Pet Medication Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 6.5.1. Key Highlights
- 6.5.1.1. China OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.2. China OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.3. China OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 6.5.1.4. China OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 6.5.1.5. Japan OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.6. Japan OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.7. Japan OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 6.5.1.8. Japan OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 6.5.1.9. South Korea OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.10. South Korea OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.11. South Korea OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 6.5.1.12. South Korea OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 6.5.1.13. India OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.14. India OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.15. India OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 6.5.1.16. India OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 6.5.1.17. Southeast Asia OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.18. Southeast Asia OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.19. Southeast Asia OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 6.5.1.20. Southeast Asia OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 6.5.1.21. Rest of Asia Pacific OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.22. Rest of Asia Pacific OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 6.5.1.23. Rest of Asia Pacific OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 6.5.1.24. Rest of Asia Pacific OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis
- 7. Latin America OTC Pet Medication Market Outlook, 2018 – 2031
- 7.1. Latin America OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 7.1.1. Key Highlights
- 7.1.1.1. Fleas & Ticks
- 7.1.1.2. Pain Relief & Arthritis
- 7.1.1.3. Dewormers
- 7.1.1.4. Others
- 7.2. Latin America OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 – 2031
- 7.2.1.1. Dogs
- 7.2.1.2. Cats
- 7.2.1.3. Birds
- 7.2.1.4. Fish & Reptiles
- 7.2.1.5. Small Pets
- 7.2.1.6. Others
- 7.3. Latin America OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 – 2031
- 7.3.1. Key Highlights
- 7.3.1.1. Chewable & Tablets
- 7.3.1.2. Capsules & Ointment
- 7.3.1.3. Sprays
- 7.3.1.4. Others
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
- 7.4. Latin America OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 – 2031
- 7.4.1.1. Pet Specialty Stores
- 7.4.1.2. Veterinary Clinics
- 7.4.1.3. Drug & Pharmacy Stores
- 7.4.1.4. Online Retail
- 7.4.1.5. Others
- 7.4.2. BPS Analysis/Market Attractiveness Analysis
- 7.5. Latin America OTC Pet Medication Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 7.5.1. Key Highlights
- 7.5.1.1. Brazil OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.2. Brazil OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.3. Brazil OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 7.5.1.4. Brazil OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 7.5.1.5. Mexico OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.6. Mexico OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.7. Mexico OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 7.5.1.8. Mexico OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 7.5.1.9. Argentina OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.10. Argentina OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.11. Argentina OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 7.5.1.12. Argentina OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 7.5.1.13. Rest of Latin America OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.14. Rest of Latin America OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 7.5.1.15. Rest of Latin America OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 7.5.1.16. Rest of Latin America OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis
- 8. Middle East & Africa OTC Pet Medication Market Outlook, 2018 – 2031
- 8.1. Middle East & Africa OTC Pet Medication Market Outlook, by Product Type, Value (US$ Bn), 2018 – 2031
- 8.1.1. Key Highlights
- 8.1.1.1. Fleas & Ticks
- 8.1.1.2. Pain Relief & Arthritis
- 8.1.1.3. Dewormers
- 8.1.1.4. Others
- 8.2. Middle East & Africa OTC Pet Medication Market Outlook, by Pet Type, Value (US$ Bn), 2018 – 2031
- 8.2.1. Key Highlights
- 8.2.1.1. Dogs
- 8.2.1.2. Cats
- 8.2.1.3. Birds
- 8.2.1.4. Fish & Reptiles
- 8.2.1.5. Small Pets
- 8.2.1.6. Others
- 8.3. Middle East & Africa OTC Pet Medication Market Outlook, by Medicine Form, Value (US$ Bn), 2018 – 2031
- 8.3.1. Key Highlights
- 8.3.1.1. Chewable & Tablets
- 8.3.1.2. Capsules & Ointment
- 8.3.1.3. Sprays
- 8.3.1.4. Others
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
- 8.4. Middle East & Africa OTC Pet Medication Market Outlook, by Sales Channel, Value (US$ Bn), 2018 – 2031
- 8.4.1. Key Highlights
- 8.4.1.1. Pet Specialty Stores
- 8.4.1.2. Veterinary Clinics
- 8.4.1.3. Drug & Pharmacy Stores
- 8.4.1.4. Online Retail
- 8.4.1.5. Others
- 8.4.2. BPS Analysis/Market Attractiveness Analysis
- 8.5. Middle East & Africa OTC Pet Medication Market Outlook, by Country, Value (US$ Bn), 2018 – 2031
- 8.5.1. Key Highlights
- 8.5.1.1. GCC OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.2. GCC OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.3. GCC OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 8.5.1.4. GCC OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 8.5.1.5. South Africa OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.6. South Africa OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.7. South Africa OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 8.5.1.8. South Africa OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 8.5.1.9. Egypt OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.10. Egypt OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.11. Egypt OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 8.5.1.12. Egypt OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 8.5.1.13. Nigeria OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.14. Nigeria OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.15. Nigeria OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 8.5.1.16. Nigeria OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 8.5.1.17. Rest of Middle East & Africa OTC Pet Medication Market by Product Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.18. Rest of Middle East & Africa OTC Pet Medication Market by Pet Type, Value (US$ Bn), 2018 – 2031
- 8.5.1.19. Rest of Middle East & Africa OTC Pet Medication Market by Medicine Form, Value (US$ Bn), 2018 – 2031
- 8.5.1.20. Rest of Middle East & Africa OTC Pet Medication Market by Sales Channel, Value (US$ Bn), 2018 – 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis
- 9. Competitive Landscape
- 9.1. By Type vs by Pet Type Heat map
- 9.2. Manufacturer vs by Pet Type Heatmap
- 9.3. Company Market Share Analysis, 2023
- 9.4. Competitive Dashboard
- 9.5. Company Profiles
- 9.5.1. Bayer Companion Animal
- 9.5.1.1. Company Overview
- 9.5.1.2. Product Portfolio
- 9.5.1.3. Financial Overview
- 9.5.1.4. Business Strategies and Development
- 9.5.2. Boehringer Ingelheim
- 9.5.2.1. Company Overview
- 9.5.2.2. Product Portfolio
- 9.5.2.3. Financial Overview
- 9.5.2.4. Business Strategies and Development
- 9.5.3. Animal Health
- 9.5.3.1. Company Overview
- 9.5.3.2. Product Portfolio
- 9.5.3.3. Financial Overview
- 9.5.3.4. Business Strategies and Development
- 9.5.4. Ceva Sante Animate
- 9.5.4.1. Company Overview
- 9.5.4.2. Product Portfolio
- 9.5.4.3. Financial Overview
- 9.5.4.4. Business Strategies and Development
- 9.5.5. Merck Inc.
- 9.5.5.1. Company Overview
- 9.5.5.2. Product Portfolio
- 9.5.5.3. Financial Overview
- 9.5.5.4. Business Strategies and Development
- 9.5.6. Zoetis Inc
- 9.5.6.1. Company Overview
- 9.5.6.2. Product Portfolio
- 9.5.6.3. Financial Overview
- 9.5.6.4. Business Strategies and Development
- 9.5.7. Elanco
- 9.5.7.1. Company Overview
- 9.5.7.2. Product Portfolio
- 9.5.7.3. Financial Overview
- 9.5.7.4. Business Strategies and Development
- 9.5.8. Virbac SA
- 9.5.8.1. Company Overview
- 9.5.8.2. Product Portfolio
- 9.5.8.3. Financial Overview
- 9.5.8.4. Business Strategies and Development
- 9.5.9. Vetoquinol SA
- 9.5.9.1. Company Overview
- 9.5.9.2. Product Portfolio
- 9.5.9.3. Financial Overview
- 9.5.9.4. Business Strategies and Development
- 9.5.10. Frontline
- 9.5.10.1. Company Overview
- 9.5.10.2. Product Portfolio
- 9.5.10.3. Financial Overview
- 9.5.10.4. Business Strategies and Development
- 9.5.11. Zymox
- 9.5.11.1. Company Overview
- 9.5.11.2. Product Portfolio
- 9.5.11.3. Financial Overview
- 9.5.11.4. Business Strategies and Development
- 9.5.12. ChloraSeb
- 9.5.12.1. Company Overview
- 9.5.12.2. Product Portfolio
- 9.5.12.3. Financial Overview
- 9.5.12.4. Business Strategies and Development
- 9.5.13. Sulfox
- 9.5.13.1. Company Overview
- 9.5.13.2. Product Portfolio
- 9.5.13.3. Financial Overview
- 9.5.13.4. Business Strategies and Development
- 9.5.14. Adequan
- 9.5.14.1. Company Overview
- 9.5.14.2. Product Portfolio
- 9.5.14.3. Financial Overview
- 9.5.14.4. Business Strategies and Development
- 9.5.15. Dechra Pharmaceuticals PLC
- 9.5.15.1. Company Overview
- 9.5.15.2. Product Portfolio
- 9.5.15.3. Financial Overview
- 9.5.15.4. Business Strategies and Development
- 9.5.16. Nutramax Laboratories, Inc.
- 9.5.16.1. Company Overview
- 9.5.16.2. Product Portfolio
- 9.5.16.3. Financial Overview
- 9.5.16.4. Business Strategies and Development
- 10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook